BridgeBio Pharma, Inc. Increase (Decrease) in Other Operating Assets
BridgeBio Pharma, Inc. (BBIO) reported Increase (Decrease) in Other Operating Assets of $3.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-10
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $1.49M, a 15.50% decline year-over-year.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $1.79M.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$545.00K.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$742.00K, a 154.16% decline year-over-year.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$1.11M.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$1.54M, a 199.74% decline from fiscal 2023.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for fiscal 2023 was $1.55M.
- BridgeBio Pharma, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$10.97M, a 211.77% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $3.28M 10-Q · filed 2026-08-10 | $2.74M derived: sum of 3 quarters · filed 2026-08-10 | $2.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $1.79M 10-Q · filed 2026-05-07 | $1.25M derived: sum of 2 quarters · filed 2026-05-07 | $508.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.27M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.29M derived: sum of 2 quarters · filed 2026-02-24 | $474.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.11M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$742.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.02M derived: sum of 2 quarters · filed 2026-08-10 | -$568.00K 10-Q · filed 2025-10-29 | -$2.54M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $174.00K 10-Q · filed 2026-08-10 | -$1.80M derived: sum of 3 quarters · filed 2026-08-10 | -$426.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$1.59M 10-Q · filed 2026-05-07 | -$3.56M derived: sum of 2 quarters · filed 2026-05-07 | -$2.19M derived: sum of 3 quarters · filed 2026-05-07 | -$2.69M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$600.00K derived: sum of 2 quarters · filed 2026-02-24 | -$1.10M derived: sum of 3 quarters · filed 2026-02-24 | -$1.54M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $872.00K derived: sum of 2 quarters · filed 2025-10-29 | $428.00K 10-Q · filed 2025-10-29 | $3.42M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$942.00K 10-Q · filed 2025-08-05 | $2.05M derived: sum of 3 quarters · filed 2026-02-24 | $636.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$444.00K 10-Q · filed 2025-04-29 | $2.54M derived: sum of 2 quarters · filed 2026-02-24 | $1.13M derived: sum of 3 quarters · filed 2026-02-24 | $619.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.58M derived: sum of 2 quarters · filed 2026-02-24 | $1.06M derived: sum of 3 quarters · filed 2026-02-24 | $1.55M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.93M derived: sum of 2 quarters · filed 2024-11-12 | -$1.44M 10-Q · filed 2024-11-12 | -$2.32M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$515.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$32.00K 10-Q · filed 2024-08-01 | -$908.00K derived: sum of 3 quarters · filed 2025-02-20 | -$2.31M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $483.00K 10-Q · filed 2024-05-02 | -$393.00K derived: sum of 2 quarters · filed 2025-02-20 | -$1.80M derived: sum of 3 quarters · filed 2025-02-20 | -$2.59M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$876.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$2.28M derived: sum of 2 quarters · filed 2025-02-20 | -$3.07M derived: sum of 3 quarters · filed 2025-02-20 | -$10.97M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$2.19M derived: sum of 2 quarters · filed 2023-11-02 | -$10.10M 10-Q · filed 2023-11-02 | -$9.21M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$790.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$8.69M 10-Q · filed 2023-08-03 | -$7.80M derived: sum of 3 quarters · filed 2024-02-22 | -$4.60M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$7.90M 10-Q · filed 2023-05-04 | -$7.01M derived: sum of 2 quarters · filed 2024-02-22 | -$3.81M derived: sum of 3 quarters · filed 2024-02-22 | -$4.20M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $886.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $4.09M derived: sum of 2 quarters · filed 2024-02-22 | $3.70M derived: sum of 3 quarters · filed 2024-02-22 | $9.82M 10-K · filed 2024-02-22 |
| 2021-09-30 | $3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $2.82M derived: sum of 2 quarters · filed 2022-11-03 | $8.93M 10-Q · filed 2022-11-03 | $10.88M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$390.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.72M 10-Q · filed 2022-08-04 | $7.67M derived: sum of 3 quarters · filed 2023-02-23 | $6.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $6.11M 10-Q · filed 2022-05-05 | $8.06M derived: sum of 2 quarters · filed 2023-02-23 | $7.29M derived: sum of 3 quarters · filed 2023-02-23 | $7.53M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.18M derived: sum of 2 quarters · filed 2023-02-23 | $1.41M derived: sum of 3 quarters · filed 2023-02-23 | $2.15M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$771.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$540.00K derived: sum of 2 quarters · filed 2021-11-04 | $194.00K 10-Q · filed 2021-11-04 | $15.46M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $965.00K 10-Q · filed 2021-08-05 | $16.23M derived: sum of 3 quarters · filed 2022-02-25 | $15.82M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $734.00K 10-Q · filed 2021-05-06 | $16.00M derived: sum of 2 quarters · filed 2022-02-25 | $15.59M derived: sum of 3 quarters · filed 2022-02-25 | $15.81M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $15.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $14.85M derived: sum of 2 quarters · filed 2022-02-25 | $15.08M derived: sum of 3 quarters · filed 2022-02-25 | $16.93M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$188.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.66M 10-Q · filed 2020-11-05 | $2.64M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $2.08M 10-Q · filed 2020-08-11 | $3.05M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2019-03-31 | $1.85M 10-Q · filed 2020-05-14 | $2.82M derived: sum of 2 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $972.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $843.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$129.00K 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $92.00K 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |